Ellinor Patrick Thomas II reported EDIT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002137699-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Aug 6, 2026

Published

Aug 7, 2026

Ingested by INSIDER

Nov 5, 02:24 UTC

Last re-read

Nov 5, 02:24 UTC

Extracted facts

Filer

Ellinor Patrick Thomas II

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Editas Medicine, Inc. — Stock Option (right to buy)

Ticker

EDIT

Shares

103.4K

Price per share

$0

Execution date (reported)

Aug 6, 2026

Owned after transaction

103.4K shares

Days from execution to publication

1

What this establishes

Ellinor Patrick Thomas II filed this Form 4 reporting a grant or award of EDIT on Aug 6, 2026. It became public on Aug 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Ellinor Patrick Thomas IIcik:0002137699

Issuer

Editas Medicine, Inc.cik:0001650664

Revision history · 0

No field has changed since this record was first ingested.